CAS 2499499-26-0

Formel: C27H22F3N5O2

InChl: InChI=1S/C27H22F3N5O2/c28-27(29,30)21-16-19(9-10-23(21)35-11-13-37-14-12-35)26(36)32-20-5-1-3-17(15-20)7-8-18-4-2-6-22-24(18)25(31)34-33-22/h1-6,9-10,15-16H,11-14H2,(H,32,36)(H3,31,33,34)

InChI Key: JKZZCHSVFXZBAI-UHFFFAOYSA-N

SMILES: C1COCCN1C2=C(C=C(C=C2)C(=O)NC3=CC=CC(=C3)C#CC4=C5C(=CC=C4)NN=C5N)C(F)(F)F

BCR-ABL-IN-6

CAS: 2499499-26-0

BCR-ABL-IN-6, an imatinib derivative, inhibits Bcr-AblWT (4.6 nM IC50) and T315I (277 nM), for chronic myeloid leukemia study.

Formel: C₂₇H₂₂F₃N₅O₂

Farbe und Form: Solid

Molekulargewicht: 505.49

Ref: TM-T63450